ID
31378
Beskrivning
Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Nyckelord
Versioner (2)
- 2018-07-24 2018-07-24 -
- 2018-08-18 2018-08-18 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
18 augusti 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593
Patient Withdrawal from Study
- StudyEvent: ODM
Beskrivning
Reason for withdrawal from study
Alias
- UMLS CUI-1
- C0422727
- UMLS CUI-2
- C3146298
Beskrivning
Patient withdrawn from trial | Indication
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C3146298
Beskrivning
Lost to Follow-Up | Date last contact
Datatyp
date
Alias
- UMLS CUI [1]
- C1302313
- UMLS CUI [2]
- C0805839
Beskrivning
Patient withdrawn from trial; Indication; Other; Specification
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C3146298
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C2348235
Beskrivning
Explanation of withdrawal
Alias
- UMLS CUI-1
- C0422727
- UMLS CUI-2
- C0681841
Similar models
Patient Withdrawal from Study
- StudyEvent: ODM
C0011008 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C3146298 (UMLS CUI-2)
C3146298 (UMLS CUI [1,2])
C0805839 (UMLS CUI [2])
C3146298 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0681841 (UMLS CUI-2)
C0681841 (UMLS CUI [1,2])